title: Chemotherapy for breast cancer during pregnancy.
authors: Carole
authors: C
authors: Mathelin
authors: Kadour
authors: K
authors: Annane
authors: Patrick
authors: P
authors: Dufour
authors: Philippe
authors: P
authors: Liegeois
authors: Jean-Pierre
authors: JP
authors: Bergerat
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy* / Q000601:surgery; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015412:Mastectomy, Segmental; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced*
chemical_list: D015251:Epirubicin; D004317:Doxorubicin; D005472:Fluorouracil